Background While it is now apparent clinical sequelae (long COVID) may persist after acute
COVID-19, their nature, frequency and aetiology are poorly characterised. This study aims to …

The existence of a variety of symptoms with a duration beyond the acute phase of COVID-
19, is referred to as post-COVID syndrome (PCS). We aimed to report a series of patients …

Background A significant proportion of individuals experience lingering and debilitating
symptoms following acute COVID-19 infection. The National Institute for Health and Care …

Long COVID-19 may be defined as patients who, four weeks after the diagnosis of SARS-
Cov-2 infection, continue to have signs and symptoms not explainable by other causes. The …

Background: The present study aimed to determine the global prevalence of anosmia and
dysgeusia in coronavirus disease 2019 (COVID-19) patients and to assess their association …

Decreased smell function is related to brain health, future mortality, and quality of life. Most
people inflicted with the SARS-CoV-2 virus evidence some measurable smell dysfunction …

Patients with COVID-19 often complain of smell and taste disorders (STD). STD emerge
early in the course of the disease, seem to be more common in SARS-CoV-2 infection than …

Chemosensory scientists have been skeptical that reports of COVID-19 taste loss are
genuine, in part because before COVID-19 taste loss was rare and often confused with smell …

Since the worldwide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) infection, management of coronavirus disease 2019 (COVID-19) has been challenging for …

Olfactory loss has been identified as one of the common symptoms related to COVID-19
infection. Although olfactory loss is recognized, our understanding of both the extent of loss …